ATE247171T1 - Expression von heterologen genen nach einem ziel- expressionsprofil - Google Patents

Expression von heterologen genen nach einem ziel- expressionsprofil

Info

Publication number
ATE247171T1
ATE247171T1 AT94913175T AT94913175T ATE247171T1 AT E247171 T1 ATE247171 T1 AT E247171T1 AT 94913175 T AT94913175 T AT 94913175T AT 94913175 T AT94913175 T AT 94913175T AT E247171 T1 ATE247171 T1 AT E247171T1
Authority
AT
Austria
Prior art keywords
expression
heterologue
genes according
target
profile
Prior art date
Application number
AT94913175T
Other languages
English (en)
Inventor
Austin Gerard Smith
Peter Scott Mountford
Richard Frank Lathe
Original Assignee
Univ Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27266666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE247171(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939308271A external-priority patent/GB9308271D0/en
Priority claimed from GB939313323A external-priority patent/GB9313323D0/en
Priority claimed from GB9401011A external-priority patent/GB9401011D0/en
Application filed by Univ Edinburgh filed Critical Univ Edinburgh
Application granted granted Critical
Publication of ATE247171T1 publication Critical patent/ATE247171T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/60—Vectors containing traps for, e.g. exons, promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Lubricants (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT94913175T 1993-04-21 1994-04-21 Expression von heterologen genen nach einem ziel- expressionsprofil ATE247171T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB939308271A GB9308271D0 (en) 1993-04-21 1993-04-21 Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
GB939313323A GB9313323D0 (en) 1993-06-28 1993-06-28 Expression of heterologous genes
GB9401011A GB9401011D0 (en) 1994-01-20 1994-01-20 Expression of heterologous genes
PCT/GB1994/000849 WO1994024301A1 (en) 1993-04-21 1994-04-21 Expression of heterologous genes according to a targeted expression profile

Publications (1)

Publication Number Publication Date
ATE247171T1 true ATE247171T1 (de) 2003-08-15

Family

ID=27266666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94913175T ATE247171T1 (de) 1993-04-21 1994-04-21 Expression von heterologen genen nach einem ziel- expressionsprofil

Country Status (12)

Country Link
US (3) US6150169A (de)
EP (2) EP0695361B2 (de)
JP (3) JP4375759B2 (de)
AT (1) ATE247171T1 (de)
AU (1) AU678234B2 (de)
CA (1) CA2161088A1 (de)
DE (1) DE69433034T3 (de)
DK (1) DK0695361T4 (de)
IL (1) IL109382A (de)
NZ (1) NZ265091A (de)
SG (1) SG48698A1 (de)
WO (1) WO1994024301A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2161088A1 (en) 1993-04-21 1994-10-27 Austin Gerard Smith Expression of heterologous genes according to a targeted expression profile
DE19514310A1 (de) * 1995-04-18 1996-10-24 Univ Ludwigs Albert Vektoren zur Transfektion von eukaryotischen Zellen, deren Verwendung und damit transfizierte Zielzellen
GB9524973D0 (en) 1995-12-06 1996-02-07 Lynxvale Ltd Viral vectors
US5928888A (en) * 1996-09-26 1999-07-27 Aurora Biosciences Corporation Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
US7332338B2 (en) 1996-10-04 2008-02-19 Lexicon Pharmaceuticals, Inc. Vectors for making genomic modifications
AU736267B2 (en) * 1996-12-31 2001-07-26 Omeros Corporation Vectors and methods for the mutagenesis of mammalian genes
US6245564B1 (en) 1997-01-23 2001-06-12 Cornell Research Foundation, Inc. Method for separating cells
EP1034257A2 (de) * 1997-11-28 2000-09-13 Medical Research Council Yac vektoren
US6808921B1 (en) 1998-03-27 2004-10-26 Lexicon Genetics Incorporated Vectors for gene mutagenesis and gene discovery
US6436707B1 (en) * 1998-03-27 2002-08-20 Lexicon Genetics Incorporated Vectors for gene mutagenesis and gene discovery
JP2002511257A (ja) * 1998-04-14 2002-04-16 カイロン コーポレイション 目的の遺伝子を発現するための非クローニング技術
GB9819912D0 (en) 1998-09-11 1998-11-04 Univ Edinburgh Propagation and/or derivation of embryonic stem cells
US7531715B1 (en) 1999-01-13 2009-05-12 Ppl Therapeutics (Scotland) Double nuclear transfer method and results thereof
US20050060101A1 (en) * 1999-06-28 2005-03-17 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US20040225449A1 (en) * 1999-06-28 2004-11-11 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
US6692916B2 (en) * 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US6960439B2 (en) * 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US20060115826A1 (en) * 1999-06-28 2006-06-01 Michael Bevilacqua Gene expression profiling for identification monitoring and treatment of multiple sclerosis
US7265262B2 (en) 2001-03-21 2007-09-04 Roslin Institute (Edinburgh) Telomerizing nuclear donor cells and improving the efficiency on nuclear transfer
US20030003581A1 (en) * 2001-06-06 2003-01-02 Economides Aris N. Method for targeting transcriptionally active loci
US7473557B2 (en) * 2001-06-06 2009-01-06 Regeneron Pharmaceuticals, Inc. Method for targeting transcriptionally active loci
WO2003040404A1 (en) 2001-11-09 2003-05-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
EP1452093A4 (de) * 2001-11-15 2007-08-15 Kirin Brewery Chimäres nichtmenschliches tier
US20030157641A1 (en) * 2001-11-16 2003-08-21 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
CN101535340B (zh) * 2006-05-19 2013-05-01 格利科菲公司 促红细胞生成素组合物
EP2024496B1 (de) 2006-06-01 2015-04-08 Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg Mit dem zellulären ph-wert assoziierte pflanzliche nukleinsäuren und deren verwendungen
CN102811800A (zh) * 2010-02-18 2012-12-05 泰尼-普雷有限公司 具有抗微生物性质的通气系统
EP2383339A1 (de) * 2010-04-27 2011-11-02 Harald Von Melchner Gen-Trapping zur Verwendung bei der Gen-Therapie
US9303272B2 (en) * 2011-12-13 2016-04-05 Public University Corporation Yokohama City University Gene targeting vector, and method for using same
WO2013158309A2 (en) * 2012-04-18 2013-10-24 The Board Of Trustees Of The Leland Stanford Junior University Non-disruptive gene targeting
CN106460009A (zh) 2014-03-21 2017-02-22 小利兰·斯坦福大学托管委员会 无核酸酶的基因组编辑
US20190284582A1 (en) 2016-11-03 2019-09-19 Temple University-Of The Commonwealth System Of Higher Education DNA Plasmids for the Fast Generation of Homologous Recombination Vectors for Cell Line Development
DE112019005166T5 (de) 2018-10-16 2021-07-29 Blueallele, Llc Verfahren zur gezielten insertion von dna in gene
CN117157049A (zh) 2021-01-24 2023-12-01 迈克尔·大卫·福雷斯特 Atp合酶抑制剂-化妆品和治疗用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646438B1 (fr) * 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
CA2045175C (en) * 1989-11-06 2003-03-18 Arthur I. Skoultchi Production of proteins using homologous recombination
AU664847B2 (en) * 1991-05-15 1995-12-07 Cell Genesys, Inc. Genomic modifications with homologous DNA targeting
AU2778992A (en) * 1991-10-07 1993-05-03 Idaho Research Foundation Inc., The Genetic construct for selection of homologous recombinants on a single selective medium
PT101031B (pt) * 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
CA2161088A1 (en) 1993-04-21 1994-10-27 Austin Gerard Smith Expression of heterologous genes according to a targeted expression profile
US6248934B1 (en) * 1998-10-26 2001-06-19 The Regents Of The University Of California Gene trap vectors

Also Published As

Publication number Publication date
DE69433034D1 (de) 2003-09-18
EP1403376A3 (de) 2007-08-29
DK0695361T3 (da) 2003-10-27
IL109382A0 (en) 1994-07-31
JP4375759B2 (ja) 2009-12-02
JP2009017889A (ja) 2009-01-29
EP0695361A1 (de) 1996-02-07
CA2161088A1 (en) 1994-10-27
US7005299B1 (en) 2006-02-28
AU6542794A (en) 1994-11-08
AU678234B2 (en) 1997-05-22
DE69433034T3 (de) 2010-04-15
WO1994024301A1 (en) 1994-10-27
DE69433034T2 (de) 2004-06-09
IL109382A (en) 2005-08-31
US6150169A (en) 2000-11-21
EP1403376A2 (de) 2004-03-31
SG48698A1 (en) 1998-05-18
EP0695361B1 (de) 2003-08-13
US20090241207A1 (en) 2009-09-24
JP2007306942A (ja) 2007-11-29
DK0695361T4 (da) 2010-03-22
JPH09500005A (ja) 1997-01-07
NZ265091A (en) 1997-07-27
EP0695361B2 (de) 2009-11-11

Similar Documents

Publication Publication Date Title
ATE247171T1 (de) Expression von heterologen genen nach einem ziel- expressionsprofil
Korn et al. The reactivation of developmentally inert 5S genes in somatic nuclei injected into Xenopus oocytes
TR200002503T2 (tr) Yeni bitki plastid promotör sekansı
AU7833494A (en) Enhanced expression in plants using non-translated leader sequences
PT917571E (pt) Gene relacionado com agouti
ATE102993T1 (de) Virale expressionsinhibitoren.
EP1471926A4 (de) Zusammensetzungen und verfahren zur therapeutischen anwendung einer mit dem gen atonal assoziierten sequenz
ATE481489T1 (de) Für den export verzweigtkettiger aminosäuren kodierende nukleotidsequenzen, verfahren zu deren isolierung und ihre verwendung
DK0630409T3 (da) Defekt-pakkende ikke-onkovirus-vektorer baseret på MPMV
DE3751368D1 (de) gentechnische Herstellung von Faktor XIIIa.
CY1108240T1 (el) ΑΠΟΜΟΝΩΜΕΝΑ ΠΟΛΥΝΟΥΚΛΕΟΤΙΔΙΑ ΤΑ ΟΠΟΙΑ ΕΧΟΥΝ ΕΝΑ ΜΕΙΩΜΕΝΟ ΠΕΡΙΕΧΟΜΕΝΟ ΜΟΤΙΒΩΝ 5΄CpG3΄ ΕΠΙΓΕΝΕΤΙΚΟΥ ΕΛΕΓΧΟΥ ΚΑΙ ΟΙ ΧΡΗΣΕΙΣ ΤΟΥΣ
EP0241446A3 (en) Enhanced protein production in bacteria by employing a novel ribosome binding site
DE69740090D1 (de) Resistenz gegen Schädlinge
EP0652948A4 (de) Entwicklung eines vektors zur erreichung von genexpression in der epidermis transgener tiere.
ATE100495T1 (de) Rekombinantes marek-krankheitsvirus, verfahren zu seiner herstellung, und vakzine.
DE3688383D1 (de) Rekombinantes vektorsystem fuer metalloproteinase-inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren.
Graus et al. The sequence of the leading region of the resistance plasmid R1.
IL101097A0 (en) Genetic manipulation of myxobacteria
CA2110266A1 (en) Enhancement of Expression by Gene Targeting in Endogenous Retrovirus-Like Sequences
ES2039390T3 (es) Un procedimiento para producir un factor de diferenciacion de celulas b humanas.
FI960951A (fi) Akarboosibiosynteesigeenejä Actinoplanes sp:stä, menetelmiä niiden eristämiseksi sekä niiden käyttö
EP0777730A4 (de) Dna-vektor für knochenspezifische genexpression
DE3783949D1 (de) Gentamicin-resistenzgene und ihre verwendung als marker.
SU1433019A1 (ru) Рекомбинантна плазмидна ДНК pIFN- @ тRр, кодирующа синтез человеческого иммунного интерферона
DE69534246D1 (de) Mn-gen und -protein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties